NCBiotech News

Raleigh's Collaborations Pharmaceuticals is partnering with universities, foundations and other companies to develop drugs that treat rare and neglected diseases, but it's also targeting COVID-19 now. 

Appalachian State University faculty members have developed a free app to allow people around the world log the activity of bees and other pollinators.

NC Med Tech Firm BioMedInnovations Gets FDA OK for Innovative COVID-19 Ventilator Developed wIth Rare Partnerships, from NASCAR to Lawrence Livermore

Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, is adding 300 more to its Clayton workforce as part of a $351.6 million expansion there.

A transformative Belgian crop protection company, Biotalys NV, is establishing U.S. headquarters in Research Triangle Park.

Cary-based startup Atom Bioworks plans to use artificial intelligence and nanotechnology, boosted by a $240K NSF grant, to design a rapid diagnostic for COVID-19.

NCBiotech portfolio company Arrevus has landed two federal grants totaling roughly $800,000 to investigate its novel chaperone protein inhibitor, ARV-1502, ​for treating sepsis and for wound healing.

Morrisville's Q2 Solutions has inked a partnership deal with Thermo Fisher Scientific tol speed up enrollment of patients in oncology clinical trials.

A grant to help train military service members in North Carolina and Texas for biopharmaceutical manufacturing careers has been approved by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

The U.S. Army has selected Metabolon for a five-year contract to analyze the metabolic profiles of military personnel.

People at North Carolina’s huge military bases who are transitioning into civilian life are getting an amazing new opportunity, thanks to NCBiotech and its partners. 

Innovative California-based healthcare company GRAIL, Inc., will invest $103 million and create nearly 400 new jobs over the next four years in Research Triangle Park.

If you’re interested in participating in a clinical trial to solve some of the riddles of COVID-19, LabCorp can help you make that connection.

Parexel International Corp., a global contract research organization headquartered near Boston, agreed today to add 264 employees to its Durham operations and turn the site into a shared headquarters by adding some key functions to the North Carolina campus.

North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.